|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities available for sale, at fair value (net of allowances for credit losses of $— and $1.9 at June 30, 2026 and December 31, 2025, respectively; amortized cost - $9,133.1 and $8,635.3 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Equity securities at fair value | ||||||||||||||||||||
| Commercial mortgage loans on real estate, at amortized cost (net of allowances for credit losses of $6.3 and $6.7 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Premiums and accounts receivable (net of allowances for credit losses of $16.8 and $10.4 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Reinsurance recoverables (net of allowances for credit losses of $5.2 at June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Deferred acquisition costs | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Value of business acquired | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets (net of allowances for credit losses of $0.9 at June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Assets held for sale (Note 4) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Future policy benefits and expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Liability for Claims and Claims Adjustment Expense | ||||||||||||||||||||
| Commissions payable | ||||||||||||||||||||
| Reinsurance balances payable | ||||||||||||||||||||
| Funds held under reinsurance | ||||||||||||||||||||
| Accounts payable and other liabilities (including allowances for credit losses of $0.6 and $0.9 at June 30, 2026 and December 31, 2025, respectively, for the unsecured portion of the high deductible recoverables) | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Liabilities held for sale (Note 4) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common stock, par value $0.01 per share, 800,000,000 shares authorized, 51,678,269 and 52,089,008 shares issued and 49,382,180 and 49,792,919 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost; 2,296,089 shares at September 30, 2023 and December 31, 2022 | ||||||||||||||||||||
| Treasury stock, at cost; 2,296,089 shares at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
